X

TLRY

Could Tilray’s Merger with Privateer be in Jeopardy?

Tilray-Privateer Merger May be Delayed The crux of this lawsuit rests on the claim that fraudulent conveyance was committed by…

Drowning in Ditch Weed, Canada’s Oversupply Endgame

Will the rollout of new cannabis products save the industry from a mounting oversupply in 2020? We dive deep to…

Tilray to Conduct Unofficial Stock Buyback for Up to 15% of Shares

Tilray (NASDAQ: TLRY) is helping insiders cash out 20% of their shares while talking up a new two-year lockup agreement…

Aphria (APHA) Earnings – The Best of an Uninspiring Bunch

Another solid earnings report from Aphria (NYSE: APHA, TSX: APHA) for Q1 2020 makes the massive valuation gap hard to…

Is the Cannabis Industry Facing a Mass Extinction?

A guide to picking cannabis stocks that will survive and thrive no matter how bad things may seem.

Tilray Acquiring FOUR20 Retail Stores In Alberta

With new edible and vape regulations about to land in the legalized Canadian cannabis industry this fall, British Columbia-based Tilray Inc…

Tilray Execs Presenting At Barclays Consumer Conference In Boston

Following a packed itinerary of business conferences and capital raising gatherings this past spring, the number of major live presentations from…

Tilray Exporting Medical Cannabis From Portugal To Germany

Continuing to focus on international operations as Canadian legalization fails to see a surge in revenue, Tilray Inc. (NASDAQ: TLRY) just announced…

Tilray Imports CBD Capsules for U.S. Clinical Trials

As the Food And Drug Administration takes a firmer stance on the health benefit claims of CBD products, companies involved in the cannabis…